Cannula thrombophlebitis: a study in volunteers comparing polytetrafluoroethylene, polyurethane, and polyamide-ether-elastomer cannulae.
Cannulae made of polytetrafluoroethylene (PTFE: n = 11), thermoplastic polyether-urethane (TPEU: n = 11), and a new test material, polyamide-ether-elastomer (XLON: n = 10) were inserted into the veins of the dorsum of the hand in 32 healthy volunteers (10 women and 22 men), 21-50 years old. The cannulae were intended to be left in place for 5 days. No infusion was given and the dressings were not exchanged. The resulting thrombophlebitis, defined as two or more of the symptoms pain, redness, oedema and hardness, was estimated on a scale which took into account the incidence, location, intensity, and duration of the symptoms. Except for one volunteer in the XLON group, all the volunteers developed thrombophlebitis, generally observed on the third day of cannulation, and being more frequent and intense over the cannulae (P less than 0.001) and at the tip (P less than 0.01) than at the insertion sites. Pain and oedema were, on the whole, the most frequent and severe symptoms during the period of indwelling. After withdrawal, hardness was the most intense, and together with pain, the most long-lasting (up to 10 days) symptom. The differences between the materials in thrombophlebitis incidence and intensity were statistically significant only when each symptom was analysed separately. Thus, the PTFE cannulae caused more pain and hardness (probably because of greater platelet adhesion and a relatively greater stiffness), while the TPEU and XLON cannulae produced more periphlebitis (redness and oedema), probably because of potentially irritant and antigenic substances leaking from them (polyurethane oligomers and polyamide/polyethyleneglycol oligomers).
Larsson
N
N
Department of Anaesthesiology, Sahlgrenska Hospital, University of Gothenburg, Sweden.
Stenberg
K
K
Linder
L E
LE
Curelaru
I
I
D000328:Adult; D001672:Biocompatible Materials / Q000009:adverse effects; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000295:instrumentation*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004311:Double-Blind Method; D004987:Ethers / Q000009:adverse effects; D005260:Female; D006225:Hand / Q000098:blood supply*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009757:Nylons / Q000009:adverse effects; D011138:Polytetrafluoroethylene / Q000009:adverse effects; D011140:Polyurethanes / Q000009:adverse effects; D011897:Random Allocation; D013499:Surface Properties; D013924:Thrombophlebitis / Q000209:etiology* / Q000473:pathology; D013997:Time Factors
D001672:Biocompatible Materials; D004987:Ethers; D009757:Nylons; D011140:Polyurethanes; C059912:polyamide-ether-elastomer; C115016:polyetherurethane; D011138:Polytetrafluoroethylene